Evidence map›Paper›PMID 34409554›Full record

ArticleJournal of autism and developmental disorders2022

First Psychometric Properties of the Dutch Interview for Diagnostic Assessment of Autism Spectrum Disorder in Adult Males Without Intellectual Disability.

Richard Vuijk, Mathijs Deen, Arnoud Arntz, Hilde M Geurts

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of autism and developmental disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Richard VuijkSarr Autism Rotterdam (Parnassia Psychiatric Institute), Dynamostraat 18, 3083 AK, Rotterdam, The Netherlands. r.vuijk@anteszorg.nl.ORCID http://orcid.org/0000-0002-9283-359X
Mathijs DeenParnassia Psychiatric Institute, Kiwistraat 32, 2552 DH, The Hague, The Netherlands.ORCID http://orcid.org/0000-0002-3570-5524
Arnoud ArntzUniversity of Amsterdam, Postbus 15933, 1001 NK, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7992-2272
Hilde M GeurtsUniversity of Amsterdam, Postbus 15933, 1001 NK, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-4824-9660
Antes · NLLeiden University · NLParnassia Groep · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For autism spectrum disorder (ASD) in adults there are several diagnostic instruments available with a need for consideration of the psychometric properties. This study aimed to conduct a first psychometric evaluation of a new diagnostic ASD instrument, the NIDA (Dutch Interview for Diagnostic assessment of ASD in adults) in 90 adult males without intellectual disability (age 18-65 years) in the Netherlands: 30 with ASD, 30 with a Personality Disorder and 30 nonpatient controls. The interrater agreement ranged from 0.79 to 1.00, the convergent validity including sensitivity and specificity ranged from 0.76 to 1.00, and we observed an adequate concurrent criterion-related validity. These promising findings can serve as foundation for future psychometric NIDA studies in a more diverse population.

trial registrationThe Netherlands National Trial Register NTR6391. Registered 04 May 2017.

Indexed as

Autism Spectrum DisorderIntellectual DisabilityAdolescentAdultAgedEthnicityHumansMaleMiddle AgedPsychometricsReproducibility of ResultsSensitivity and SpecificityYoung AdultAutism spectrum disorder (ASD)Interrater agreementNIDAPersonality disorder (PD)Validity

Identifiers

PMID34409554
OpenAlexW3194595381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.